摘要
目的分析肺结核保守治疗中肝肾功能及血常规指标表达的意义。方法选择邹平市疾病预防控制中心2021年2月—2022年3月期间随访的肺结核患者中自愿接受抗结核药物治疗的60例作为研究对象。记录患者抗结核药物治疗前后血常规、肝肾功能指标。结果治疗后红细胞分布宽度(15.18±2.31)%、中性粒细胞/淋巴细胞比值(8.33±1.67)均高于治疗前,差异有统计学意义(t=65.410、74.586,P<0.05);治疗后谷丙转氨酶水平(37.39±10.19)U/L、总胆红素水平(10.36±2.85)μmol/L、尿酸水平(338.60±25.16)μmol/L均优于治疗前,差异有统计学意义(t=14.833、25.497、-394.326,P<0.001)。结论服用抗结核药物进行抗结核治疗的肺结核患者要谨遵医嘱,定期到医院接受血常规及肝肾功能检查,要及时处理并解决各种不良情况。
Objective To analyze the significance of liver and kidney function and blood routine index expression in the conservative treatment of pulmonary tuberculosis.Methods 60 patients with tuberculosis who were followed up by the Center for Disease Control and Prevention of Zouping City from February 2021 to March 2022 were selected as the study objects.Blood routine,liver and kidney function indexes were recorded before and after antituberculosis drug treatment.Results The width of erythrocyte distribution(15.18±2.31)%and neutrophil/lymphocyte ratio(8.33±1.67)were higher in patients after treatment than before treatment,the difference was statistically significant(t=65.410,74.586,P<0.05);glutathione transaminase(37.39±10.19)U/L,total bilirubin level(10.36±2.85)μmol/L,and uric acid level(338.60±25.16)μmol/L were better in patients after treatment than before treatment,the difference was statistically significant(t=14.833,25.497,-394.326,P<0.001).Conclusion Patients with pulmonary tuberculosis taking anti-tuberculosis drugs for anti-tuberculosis treatment should follow medical advice and receive blood routine and liver and kidney function tests regularly at the hospital,and should promptly address and resolve any adverse conditions.
作者
宗新锋
ZONG Xinfeng(Department of Laboratory,Zouping Disease Prevention and Control Center,Zouping,Shandong Province,256200 China)
出处
《系统医学》
2023年第7期70-73,共4页
Systems Medicine
关键词
肺结核
药物治疗
不良反应
治疗效果
Pulmonary tuberculosis
Drug therapy
Adverse reactions
Treatment effect
